StockData
Kazia Therapeutics Ltd logo

Kazia Therapeutics Ltd (KZIA) stock

KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$4.92−0.45 (-8.38%)

Close on Nov 20, 2026Market cap $7.96MP/E –Yield –

Kazia Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Kazia Therapeutics's price to sales ratio was 282.0× on Nov 11, 2026, against 284.4× a year earlier. Over the last 4 years it ranged from 1.3× to 495.4×, with a median of 151.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026282.0×+12.4
2025Dec 31, 2025269.6×+266.3
2024Dec 31, 20243.3×+1.5
2022Aug 31, 20221.7×−7.3
2021Dec 31, 20219.0×−131.8
2019Aug 30, 2019140.7×+0.5
2018Dec 31, 2018140.2×−260.6
2017Aug 31, 2017400.8×–

More Kazia Therapeutics figures

See a number that looks wrong?